Stimulant dependence including amphetamines, methamphetamine or methcathinone (Q40426): Difference between revisions

@@ description / pt-br / description / pt-br @@
+Dependência de estimulantes, incluindo anfetaminas, metanfetamina ou metcatinona mas excluindo cafeína, cocaína e catinonas sintéticas, é um transtorno de regulação do uso de estimulantes que surge do uso repetido ou contínuo de estimulantes. O elemento característico é um forte impulso interno para usar estimulantes, que é manifestado por capacidade prejudicada de controlar o uso, aumento da prioridade dada ao uso em detrimento de outras atividades, e persistência do uso apesar de danos ou consequências negativas. Essas experiências são frequentemente acompanhadas de uma sensação subjetiva de urgência ou fissura para usar estimulantes. Aspectos fisiológicos da dependência também podem estar presentes, incluindo tolerância aos efeitos dos estimulantes, sintomas de abstinência após a cessação ou redução no uso de estimulantes, ou uso repetido de estimulantes ou substâncias farmacologicamente semelhantes para prevenir ou aliviar os sintomas de abstinência. As manifestações da dependência geralmente são evidentes durante um período de pelo menos 12 meses, mas o diagnóstico pode ser feito se o uso de estimulantes for contínuo (diário ou quase diário) por pelo menos 3 meses.
@@ description / en / description / en @@
+Stimulant dependence including amphetamines, methamphetamine or methcathinone but excluding cocaine and synthetic cathinones is a disorder of regulation of stimulant use arising from repeated or continuous use of stimulants. The characteristic feature is a strong internal drive to use stimulants, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use stimulants. Physiological features of dependence may also be present, including tolerance to the effects of stimulants, withdrawal symptoms following cessation or reduction in use of stimulants, or repeated use of stimulants or pharmacologically similar substances to prevent or alleviate withdrawal symptoms. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if stimulant use is continuous (daily or almost daily) for at least 3 months.
@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/2016549355
@@ Property / Canonical URI: https://id.who.int/icd/entity/2016549355 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:6C46.2
@@ Property / CURIE: CID11:6C46.2 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-6C46.2
@@ Property / Canary Token: dki-india-6C46.2 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+F15.2
@@ Property / Linked ICD 10: F15.2 / rank @@
+Normal rank

Latest revision as of 06:13, 13 August 2026

Stimulant dependence including amphetamines, methamphetamine or methcathinone but excluding cocaine and synthetic cathinones is a disorder of regulation of stimulant use arising from repeated or continuous use of stimulants. The characteristic feature is a strong internal drive to use stimulants, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use stimulants. Physiological features of dependence may also be present, including tolerance to the effects of stimulants, withdrawal symptoms following cessation or reduction in use of stimulants, or repeated use of stimulants or pharmacologically similar substances to prevent or alleviate withdrawal symptoms. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if stimulant use is continuous (daily or almost daily) for at least 3 months.

Language	Label	Description	Also known as
default for all languages	6C46.2
English	Stimulant dependence including amphetamines, methamphetamine or methcathinone	Stimulant dependence including amphetamines, methamphetamine or methcathinone but excluding cocaine and synthetic cathinones is a disorder of regulation of stimulant use arising from repeated or continuous use of stimulants. The characteristic feature is a strong internal drive to use stimulants, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use stimulants. Physiological features of dependence may also be present, including tolerance to the effects of stimulants, withdrawal symptoms following cessation or reduction in use of stimulants, or repeated use of stimulants or pharmacologically similar substances to prevent or alleviate withdrawal symptoms. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if stimulant use is continuous (daily or almost daily) for at least 3 months.